Cite
HARVARD Citation
Goswami, M. et al. (2022). Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. Journal for immunotherapy of cancer. 10 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goswami, M. et al. (2022). Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia. Journal for immunotherapy of cancer. 10 (1), p. . [Online].